ARQ-151 cream 0.05%
ARQ-151-218
Phase 2 small_molecule completed
Quick answer
ARQ-151 cream 0.05% for Atopic Dermatitis (Eczema) is a Phase 2 program (small_molecule) at Arcutis Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Arcutis Biotherapeutics
- Indication
- Atopic Dermatitis (Eczema)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed